167 related articles for article (PubMed ID: 10721817)
21. Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.
Jacques D; Sader S; El-Bizri N; Chouffani S; Hassan G; Shbaklo H
Can J Physiol Pharmacol; 2000 Feb; 78(2):162-72. PubMed ID: 10737679
[TBL] [Abstract][Full Text] [Related]
22. Potentiation by neuropeptide Y of histamine H1 receptor-mediated contraction in rat blood vessels.
Piao H; Nagai S; Tsurumaki T; Niki T; Higuchi H
Vascul Pharmacol; 2007 Apr; 46(4):260-70. PubMed ID: 17169617
[TBL] [Abstract][Full Text] [Related]
23. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Dhillon SS; Gingerich S; Belsham DD
Regul Pept; 2009 Aug; 156(1-3):96-103. PubMed ID: 19371763
[TBL] [Abstract][Full Text] [Related]
25. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
26. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
27. Involvement of neuropeptide Y Y1 receptors in the regulation of LH and GH cells in the pituitary of the catfish, Clarias batrachus: an immunocytochemical study.
Mazumdar M; Lal B; Sakharkar AJ; Deshmukh M; Singru PS; Subhedar N
Gen Comp Endocrinol; 2006 Nov; 149(2):190-6. PubMed ID: 16828090
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor.
Bergdahl A; Nilsson T; Cantera L; Nilsson L; Sun XY; Hedner T; Erlinge D; Valdemarson S; Edvinsson L
Eur J Pharmacol; 1996 Nov; 316(1):59-64. PubMed ID: 8982651
[TBL] [Abstract][Full Text] [Related]
29. Effects of the neuropeptide Y (NPY)-receptor antagonist BIBP3226 on vascular NPY-receptors with different ligand requirements.
Grundemar L; Ekelund M
Pharmacol Toxicol; 1996 Nov; 79(5):266-9. PubMed ID: 8936561
[TBL] [Abstract][Full Text] [Related]
30. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
31. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y
Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373
[TBL] [Abstract][Full Text] [Related]
32. Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling.
García-Villalón AL; Padilla J; Fernández N; Monge L; Martínez MA; Gómez B; Diéguez G
Pflugers Arch; 2000 Aug; 440(4):548-55. PubMed ID: 10958338
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.
Movafagh S; Hobson JP; Spiegel S; Kleinman HK; Zukowska Z
FASEB J; 2006 Sep; 20(11):1924-6. PubMed ID: 16891622
[TBL] [Abstract][Full Text] [Related]
34. Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors.
Bhisikar SM; Kokare DM; Nakhate KT; Chopde CT; Subhedar NK
Life Sci; 2009 Nov; 85(21-22):765-72. PubMed ID: 19846044
[TBL] [Abstract][Full Text] [Related]
35. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
Kask A; Schiöth HB; Harro J; Wikberg JE; Rägo L
Can J Physiol Pharmacol; 2000 Feb; 78(2):143-9. PubMed ID: 10737677
[TBL] [Abstract][Full Text] [Related]
36. Potentiation by neuropeptide Y of 5HT2A receptor-mediated contraction in porcine coronary artery.
Tsurumaki T; Nagai S; Bo X; Toyosato A; Higuchi H
Eur J Pharmacol; 2006 Aug; 544(1-3):111-7. PubMed ID: 16844110
[TBL] [Abstract][Full Text] [Related]
37. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
38. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
Odagaki Y; Nishi N; Nakagawa S; Koyama T
J Pharmacol Exp Ther; 1999 Dec; 291(3):1250-6. PubMed ID: 10565849
[TBL] [Abstract][Full Text] [Related]
39. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
Gradin KA; Buus CL; Li JY; Frøbert O; Simonsen U
Br J Pharmacol; 2006 Jul; 148(5):703-13. PubMed ID: 16715120
[TBL] [Abstract][Full Text] [Related]
40. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
